FDA Cracks Down on Scary Imports That Impact Public Safety

Posted by & filed under Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Financial Accounting, Financial Reporting and Analysis, Financial Statement Analysis, Fraud Accounting, IFRS, Intermediate Accounting, International Accounting, Managerial Accounting.

India is the second largest exporter of over-the-counter and prescription drugs to the U.S. However, the FDA has recently increased their inspections of these manufacturers due to falsified drug test results, safety lapses, and the sale of fake medicines.

Questions:
1. What percentage of U.S. over-the-counter and generic prescription drugs are supplied by India manufacturers?
2. What generic prescription drugs were recently banned? Research what each of the are used for and why this is so dangerous.
3. What are some of the statistics associated with the FDA’s increased scrutiny of Indian drug plants? How would you assess the cost effectiveness of this campaign?

Sources:

Harris, Gardner.(2014). Medicines Made in India Set Off Safety Worries. The New York Times, Feb. 14 (Retrievable online at http://www.nytimes.com/2014/02/15/world/asia/medicines-made-in-india-set-off-Indian drugssafety-worries.html?hp&_r=0).